Dong Z - Search Results

1

Cell Block as a Surrogate for Programmed Death-Ligand 1 Staining Testing in Patients of Non-Small Cell Lung Cancer.

Dong Z, Liu Y, Jiang T, Hou L, Wu F, Gao G, Li X, Zhao C, Wang Y, Yang S, Mao S, Liu Q, Li Y, Xu C, Wu C, Ren S, Zhou C, Zhang J, Hirsch FR. Dong Z, et al. J Cancer. 2020 Jan 1;11(3):551-558. doi: 10.7150/jca.35810. eCollection 2020. J Cancer. 2020. PMID: 31942178 Free PMC article.

2

[Expression of p63, p40 and CK5/6 in small cell lung cancer].

Zhang L, Hou L, Xie H, Dong Z, Wu W, Kong J, Chen G, Wu C. Zhang L, et al. Among authors: dong z. Zhonghua Bing Li Xue Za Zhi. 2015 Sep;44(9):644-7. Zhonghua Bing Li Xue Za Zhi. 2015. PMID: 26705280 Chinese.

3

High concordance of ALK rearrangement between primary tumor and paired metastatic lymph node in patients with lung adenocarcinoma.

Hou L, Ren S, Su B, Zhang L, Wu W, Zhang W, Dong Z, Huang Y, Wu C, Chen G. Hou L, et al. Among authors: dong z. J Thorac Dis. 2016 Jun;8(6):1103-11. doi: 10.21037/jtd.2016.03.96. J Thorac Dis. 2016. PMID: 27293826 Free PMC article.

4

Evaluation of cytology in lung cancer diagnosis based on EBUS-TBNA.

Dong Z, Li H, Jiang H, Wu C. Dong Z, et al. J Cytol. 2017 Apr-Jun;34(2):73-77. doi: 10.4103/0970-9371.203567. J Cytol. 2017. PMID: 28469313 Free PMC article.

5

The value of cell block based on fine needle aspiration for lung cancer diagnosis.

Dong Z, Li H, Zhou J, Zhang W, Wu C. Dong Z, et al. J Thorac Dis. 2017 Aug;9(8):2375-2382. doi: 10.21037/jtd.2017.07.91. J Thorac Dis. 2017. PMID: 28932542 Free PMC article.

6

Heterogeneity of PD-L1 Expression Among the Different Histological Components and Metastatic Lymph Nodes in Patients With Resected Lung Adenosquamous Carcinoma.

Liu Y, Dong Z, Jiang T, Hou L, Wu F, Gao G, He Y, Zhao J, Li X, Zhao C, Zhang W, Tian Q, Pan Y, Wang Y, Yang S, Wu C, Ren S, Zhou C, Zhang J, Hirsch FR. Liu Y, et al. Among authors: dong z. Clin Lung Cancer. 2018 Jul;19(4):e421-e430. doi: 10.1016/j.cllc.2018.02.008. Epub 2018 Mar 31. Clin Lung Cancer. 2018. PMID: 29609906

7

Intraoperatively measured tumor size and frozen section results should be considered jointly to predict the final pathology for lung adenocarcinoma.

Zhu E, Xie H, Dai C, Zhang L, Huang Y, Dong Z, Guo J, Su H, Ren Y, Shi P, Fu R, Qin S, Wu C, Chen C. Zhu E, et al. Among authors: dong z. Mod Pathol. 2018 Sep;31(9):1391-1399. doi: 10.1038/s41379-018-0056-0. Epub 2018 May 11. Mod Pathol. 2018. PMID: 29752477 Free article.

8

A lung squamous carcinoma patient with ROS1 rearrangement sensitive to crizotinib.

Ju L, Han M, Su J, Wu C, Dong Z. Ju L, et al. Among authors: dong z. Cancer Chemother Pharmacol. 2018 Sep;82(3):561-564. doi: 10.1007/s00280-018-3660-2. Epub 2018 Aug 6. Cancer Chemother Pharmacol. 2018. PMID: 30083883

9

Predictive value of oncogenic driver subtype, programmed death-1 ligand (PD-L1) score, and smoking status on the efficacy of PD-1/PD-L1 inhibitors in patients with oncogene-driven non-small cell lung cancer.

Ng TL, Liu Y, Dimou A, Patil T, Aisner DL, Dong Z, Jiang T, Su C, Wu C, Ren S, Zhou C, Camidge DR. Ng TL, et al. Among authors: dong z. Cancer. 2019 Apr 1;125(7):1038-1049. doi: 10.1002/cncr.31871. Epub 2018 Dec 11. Cancer. 2019. PMID: 30548240 Free article.

10

Genomic landscape and its correlations with tumor mutational burden, PD-L1 expression, and immune cells infiltration in Chinese lung squamous cell carcinoma.

Jiang T, Shi J, Dong Z, Hou L, Zhao C, Li X, Mao B, Zhu W, Guo X, Zhang H, He J, Chen X, Su C, Ren S, Wu C, Zhou C. Jiang T, et al. Among authors: dong z. J Hematol Oncol. 2019 Jul 12;12(1):75. doi: 10.1186/s13045-019-0762-1. J Hematol Oncol. 2019. PMID: 31299995 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

10,615 results

Search Page

Filters